Nov/12/2009 12:01 Filed in:
FDA Social
Media
The first day of
the FDA hearing on social media went well but I
have to admit that I am skeptical of any
government agency that wants to talk about new
media when they still classify drug product
websites as labeling. With an average annual
spend of $150,000 per primary care sales
representative and $300,000 per specialty rep,
leveraging the Internet is a more cost-effective
proxy by which to disseminate educational (meant
to persuade) information to doctors, medical
staffs, health care administrators, and patients.
The real question is though "will this have any
impact on consumers/patients?"
Read
More...
Tags: Social Media
